Augmented Reality-Based Exercise Training in Adolescents With Idiopathic Scoliosis

NCT07201103 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2025-10-01

No results posted yet for this study

Summary

This randomized controlled trial investigates the effects of augmented reality (AR)-based exercise training in adolescents with idiopathic scoliosis. Participants are randomly assigned to either a control group receiving conventional Physiotherapeutic Scoliosis-Specific Exercises (PSSE-Schroth) or an intervention group receiving AR-assisted PSSE-Schroth exercises. The primary outcomes include body awareness, trunk appearance perception, and exercise adherence. The study aims to evaluate whether AR-assisted training provides additional benefits over conventional therapy in improving postural control, perception, and compliance in scoliosis management.

Conditions

  • Adolescent Idiopathic Scoliosis

Interventions

BEHAVIORAL

Conventional PSSE-Schroth

Participants performed conventional Physiotherapeutic Scoliosis-Specific Exercises (PSSE-Schroth) for 4 weeks. The program consisted of one 45-minute supervised session per week complemented by home-based exercises. The exercises focused on posture correction, spinal alignment, and corrective breathing techniques according to standard scoliosis rehabilitation protocols.

BEHAVIORAL

AR-Assisted PSSE-Schroth

Participants performed Physiotherapeutic Scoliosis-Specific Exercises (PSSE-Schroth) enhanced with augmented reality (AR) support for 4 weeks. The intervention included one 45-minute supervised session per week, plus home-based exercises. The AR system provided real-time visual and kinesthetic feedback during exercise sessions to improve body awareness, trunk appearance perception, and adherence.

Sponsors & Collaborators

  • The Scientific and Technological Research Council of Turkey

    collaborator OTHER
  • Hasan Kalyoncu University

    lead OTHER

Principal Investigators

  • Adnan B Coşkun, PhD · Hasan Kalyoncu University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
10 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-01-01
Primary Completion
2025-07-01
Completion
2025-09-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07201103 on ClinicalTrials.gov